title: Johnson & Johnson Q3 Earnings Surprise, Icotrokinra Shines Again
source: SeekingAlpha
date: 2025-10-14
url: https://finnhub.io/api/news?id=2d338e41d2ed5636b2c4f31ccf41db9670c3f47ddb04a5f8f264d19468c2cead
Johnson & Johnson's Q3 2025 earnings beat forecasts, with strong oncology sales and raised guidance. Click for my updated look at JNJ stock prospects.
